tirzepatide 15 mg vial MOUNJARO / 0.5 ML ( ) FOR SUBCUTANEOUS INJECTION 4 VIALS Mounjaro Tirzepatide 15 Mg Injection

Batch Number: 19380/A - 19380/B Molecular Formula: C78H123N23O23S2 Peptide Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe Research Only: Yes Purity: 99%+ Heavy Metals Report : See Report Endotoxin Test: See report Form: Lyophilised Solid Mixing Water Required: Yes Usage and Storage: AOD9604 is provided in lyophilised powder form for enhanced stability

This advanced formula targets four key signs of aging deflation, deep wrinkles, dehydration, and density loss to help restore a firm, youthful complexion

Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential

Recently, it has gained prominence for its potential benefits in promoting weight loss and improving overall well-being.

As oral semaglutide and higher dulaglutide doses are recent to the market, additional real-world evidence is required to evaluate utilization patterns

Medical Notes 8